6th International Conference: Genomic Medicine Implementation in Low Resource Settings

第六届国际会议：资源匮乏环境下的基因组医学实施

• 批准号: 10318318
• 负责人: GABRIELA REPETTO
• 金额: $ 3.64万
• 依托单位: GLOBAL GENOMIC MEDICINE COLLABORATIVE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-21 至 2022-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10318318
• 关键词: Academia; Achievement; Advocate; Affect; COVID-19 pandemic; Caring; Chile; Clinical Trials; Collaborations; Communities; Country; Development; Diagnosis; Discipline; Disease; Education; Elements; Epidemiologist; Event; Family; Fostering; Future; Genomic medicine; Genomics; Geography; Goals; Government; Health; Health Personnel; Health system; Healthcare; Human; Hybrids; Income; Individual; Industry; International; Investments; Latin America; Lead; Leadership; Location; Malignant Neoplasms; Mentors; Mentorship; Outcome; Participant; Patients; Persons; Pharmacogenomics; Physicians; Play; Policies; Policy Maker; Population Heterogeneity; Prevention; Privatization; Probability; Rare Diseases; Recording of previous events; Research; Research Personnel; Resources; Risk; Role; Scientist; System; Time; Training; Travel; Uncertainty; Underrepresented Populations; United States; Work; base; career; career development; clinical application; cost; demographics; evidence based guidelines; health care availability; health care delivery; implementation science; improved; meetings; member; outreach; patient population; population health; posters; programs; success; symposium; therapeutic development; virtual; working group

Abstract The Global Genomics Medicine Collaborative (G2MC) requests support for its 6th International Conference: Genomic Medicine Implementation in Low Resource Settings, organized by Drs. Geoffrey S. Ginsburg, Gabriela Repetto and Bruce Korf. The event will be held on September 29 - October 1, 2021 in Santiago, Chile. G2MC is a not-for-profit organization based in the United States with the goal of bringing together the global community to enable the implementation of genomic medicine to improve individual and population health. Many nations are investing in large-scale national genomic medicine programs. To maximize the value of this investment, we propose this gathering as a means to ‘de-silo’ these efforts and bring them together to inform implementation into healthcare delivery systems across diverse populations, demographics, and economies. To optimize the probability of success for implementing genomics into health care is it necessary to bring the leaders at the forefront of genomic medicine together in a forum conducive to impactful conversations and dialogues. While genomic medicine offers major opportunities for prevention, diagnosis, and treatment of disease, there is a significant risk that it will exacerbate disparities in access to healthcare. This is true in high-income countries such as the United States but is even more a concern in low resource settings (LRS). G2MC has selected the event location to enable engagement with regional attendees from Latin America, a traditionally underrepresented group in genomic medicine. The conference agenda will facilitate a deeper understanding of best practices from subject matter experts that can be applied to genomic medicine and advancement of G2MC’s implementation Flagship Projects. The conference will also provide a unique opportunity to mentor Young Investigators (YIs) from lower- and middle-resourced countries in Latin America and beyond by established G2MC investigators and high-profile speakers from around the world with expertise in genomic medicine. Given the current COVID-19 pandemic, this meeting is planned as a hybrid in-person and virtual event. G2MC will encourage YIs to attend in person, if possible, so as to increase their visibility, and highlight their achievements. An explicit goal of this meeting is to advance the careers of YIs through their interaction with G2MC members/investigators through mentorship, networking, dissemination of their research. YIs will also engage with G2MC Flagship Projects and working groups, leading to further opportunities for collaboration. The 6th International G2MC Conference is unique in emphasizing implementation through outreach with YIs as well as speaker and attendee representation from LRS. The agenda objectives emphasize solutions to implementation roadblocks by engaging with a truly global group of presenters and attendees to enable the successful implementation of genomic medicine around the world.

抽象的 全球基因组医学合作组织 (G2MC) 请求为其第六届国际会议提供支持： 资源匮乏环境中的基因组医学实施，由 Geoffrey S. Ginsburg 博士组织， Gabriela Repetto 和 Bruce Korf 该活动将于 2021 年 9 月 29 日至 10 月 1 日在圣地亚哥举行。 G2MC 是一家总部位于美国的非营利组织，其目标是将全球各地的人们聚集在一起。 全球社会致力于实施基因组医学以改善个人和人口 许多国家正在投资大规模的国家基因组医学计划，以实现价值最大化。 对于这项投资，我们建议这次聚会作为“去孤立”这些努力的一种手段，并将它们聚集在一起 为不同人群、人口统计数据和不同人群的医疗保健提供系统的实施提供信息 为了最大限度地提高将基因组学应用于医疗保健的成功概率，这是必要的。 将基因组医学前沿的领导者聚集在一个有利于产生影响力的论坛上 而基因组医学为预防、诊断和治疗提供了重要机会。 疾病的治疗，存在着加剧获得医疗保健方面的差距的重大风险。 在美国等高收入国家确实如此，但在资源匮乏的环境中更令人担忧 (LRS) 选择活动地点是为了与来自拉丁地区的与会者进行交流。 美国是基因组医学领域传统上代表性不足的群体，会议议程将促进 更深入地了解主题专家可应用于基因组医学的最佳实践 会议还将提供独特的G2MC旗舰项目实施和推进。 有机会指导来自拉丁美洲中低资源国家的青年研究者 (YIs) 以及来自世界各地具有专业知识的知名 G2MC 调查人员和知名演讲者的精彩演讲 鉴于当前的 COVID-19 大流行，本次会议计划为混合面对面会议。 如果可能的话，G2MC 将鼓励 YI 亲自参加，以提高他们的知名度，以及 突出他们的成就，本次会议的一个明确目标是通过他们来推动 YI 的职业发展。 通过指导、网络、传播研究成果与 G2MC 成员/研究人员互动。 YIs 还将与 G2MC 旗舰项目和工作组合作，为以下项目带来更多机会： 第六届G2MC国际会议的独特之处在于强调通过合作来实施。 与 YIs 的外展以及来自 LRS 的演讲者和与会者代表 议程目标。 通过与真正的全球演讲者团队合作来强调障碍的解决方案， 与会者共同推动基因组医学在世界各地的成功实施。